お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
961190

世界の糖鎖生物学市場規模調査:製品別、用途別、エンドユーザー別、地域別予測(2020年~2027年)

Global Glycobiology Market Size study, by Product, by Application, by End-user and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.61円
世界の糖鎖生物学市場規模調査:製品別、用途別、エンドユーザー別、地域別予測(2020年~2027年)
出版日: 2020年09月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の糖鎖生物学の市場規模は、2019年に約10億4千万米ドルとなりました。同市場は、予測期間の2020~2027年にわたって14.64%を超える健全な成長率で成長すると予想されています。

糖鎖生物学は、糖類(糖鎖またはグリカン)の形成、生合成と生物学を研究する分野です。糖鎖生物学は、生物学全体を網羅する分野であり、グリカンとしても知られる炭水化物含有分子(糖類)の構造と機能が含まれます。市場の主な推進力となるのは、プロテオミクスおよびグリコミクス研究への資金の増加、 研究開発への投資の増加、およびグリコミクス機器の技術的進歩などです。さらに、R&Dおよび製薬業界におけるバイオテクノロジーとプロテオミクスの進歩により、予測期間中に市場における需要が大きな成長機会を生み出すと予測されています。ただし、厳格な規制の枠組みと市場での高度な統合により、予測期間中に市場に大きな障壁が生じることが予想されます。

これとは別に、 世界の糖鎖生物学市場の主要なプレーヤーは、製品の発売、合併と買収、提携と協定、投資、資金調達など、競争上の優位性を得るためにさまざまな戦略を採用しています。たとえば、Agilent Technologies(米国)は、2019年6月にInfinity Lab LC / MSD iQ Systemを発売しました。2018年6月に、Thermo Fisher Scientific(米国)はUHMR Hybrid Quadrupole-Orbitrap Mass Spectrometerを導入しました。 2018年、島津製作所は、多国籍バイオインフォマティクスソリューション企業のPREMIER Biosoftと提携し、LCMS-9030 Quadrupole Time of Flight (Q-TOF)という質量分析システムを導入して、高度なグリコミクスおよびリピドミクスデータ処理を実現することを目指しています。

当レポートでは、世界の糖鎖生物学市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の糖鎖生物学市場の定義と範囲

第3章 世界の糖鎖生物市場力学

  • 糖鎖生物学の市場影響分析(2018-2027)

第4章 世界の糖鎖生物学市場:エンドユーザー別:分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターの5力モデルへの未来的なアプローチ(2017-2027)
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの提言と結論

第5章 製品別世界の糖鎖生物学市場

  • 市場のスナップショット
  • 製品別世界の糖鎖生物学市場、パフォーマンス-潜在的な分析
  • 製品別世界の糖鎖生物学市場の見積と予測:2017-2027年(10億米ドル)
  • 糖鎖生物学市場、サブセグメント分析
    • 酵素
    • その他の酵素
    • 計器
    • キット
    • 炭水化物
    • 試薬・化学薬品

第6章 エンドユーザー別世界の糖鎖生物学市場

  • 市場のスナップショット
  • エンドユーザー別世界の糖鎖生物学市場、パフォーマンス-潜在的な分析
  • エンドユーザー別世界の糖鎖生物学市場の見積と予測:2017-2027年(10億米ドル)
  • 糖鎖生物学市場、サブセグメント分析
    • 学術調査機関
    • 製薬会社およびバイオテクノロジー企業
    • 臨床検査室

第7章 用途別世界の糖鎖生物学市場

  • 市場のスナップショット
  • 用途別世界の糖鎖生物学市場、パフォーマンス-潜在的な分析
  • 用途別世界の糖鎖生物学市場の見積と予測:2017-2027年(10億米ドル)
  • 糖鎖生物学市場、サブセグメント分析
    • 創薬と開発
    • 病気の診断
    • その他の用途

第8章 世界の糖鎖生物学市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Merck KGaA
    • Agilent Technologies
    • Thermo Fisher Scientific
    • New England Biolabs
    • Shimadzu Corporation
    • Takara Bio
    • S-BIO
    • Waters Corporation
    • Asparia Glycomics S.L.
    • Bio-Techne

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Glycobiology Market, report scope
  • TABLE 2. Global Glycobiology market estimates & forecasts by Region 2017-2027 (USD Billion)
  • TABLE 3. Global Glycobiology market estimates & forecasts by Product 2017-2027 (USD Billion)
  • TABLE 4. Global Glycobiology market estimates & forecasts by Application 2017-2027 (USD Billion)
  • TABLE 5. Global Glycobiology market estimates & forecasts by End-user 2017-2027 (USD Billion)
  • TABLE 6. Global Glycobiology market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Glycobiology market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Glycobiology market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Glycobiology market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Glycobiology market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Glycobiology market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Glycobiology market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Glycobiology market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Glycobiology market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Glycobiology market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. U.S. Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. U.S. Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 18. U.S. Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 19. Canada Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Canada Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 21. Canada Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 22. UK Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. UK Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. UK Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 25. Germany Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Germany Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. Germany Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 28. RoE Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. RoE Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. RoE Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. China Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 32. China Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. China Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. India Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 35. India Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. India Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 37. Japan Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 38. Japan Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Japan Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. RoAPAC Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. RoAPAC Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. RoAPAC Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. Brazil Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 44. Brazil Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. Brazil Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. Mexico Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 47. Mexico Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. Mexico Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. RoLA Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 50. RoLA Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. RoLA Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. Row Glycobiology market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 53. Row Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Row Glycobiology market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. List of secondary Applications, used in the study of global Glycobiology market
  • TABLE 56. List of primary Applications, used in the study of global Glycobiology market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Glycobiology market, research methodology
  • FIG 2. Global Glycobiology market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Glycobiology market, key trends 2019
  • FIG 5. Global Glycobiology market, growth prospects 2020-2027
  • FIG 6. Global Glycobiology market, porters 5 force model
  • FIG 7. Global Glycobiology market, pest analysis
  • FIG 8. Global Glycobiology market, value chain analysis
  • FIG 9. Global Glycobiology market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Glycobiology market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Glycobiology market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Glycobiology market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Glycobiology market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Glycobiology market, regional snapshot 2017 & 2027
  • FIG 15. North America Glycobiology market 2017 & 2027 (USD Billion)
  • FIG 16. Europe Glycobiology market 2017 & 2027 (USD Billion)
  • FIG 17. Asia pacific Glycobiology market 2017 & 2027 (USD Billion)
  • FIG 18. Latin America Glycobiology market 2017 & 2027 (USD Billion)
  • FIG 19. Global Glycobiology market, company market share analysis (2019)
目次

Title:
Global Glycobiology Market Size study, by Product (Enzymes, Other Enzymes, Instruments

Kits, Carbohydrates, Reagents & Chemicals), by Application (Drug Discovery & Development, Disease Diagnostics, Other Applications), by End-user ( Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) and Regional Forecasts 2020-2027 .

Global Glycobiology Market is valued approximately at USD 1.04 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 14.64 % over the forecast period 2020-2027. Glycobiology is the science of saccharides (sugar chains or glycans) formation, biosynthesis, and biology. Glycobiology is the science of whole biology and includes the structure and function of carbohydrate-containing molecules (sugar and saccharides) also known as glycans. Key driving forces of the market includes increase in funding for proteomics and glycomics studies, increase in investment for research and development and technological advancements in glycomics instrumentation. Additionally, advancement of biotechnology and proteomics in the R&D and pharmaceutical industry the demand is projected to create significant growth opportunity in the market over the forecast period. However, stringent regulatory frameworks and high degree of consolidation in the market is expected to create significant barrier in the market over the forecast period. Apart from this, the key players of global Glycobiology market have adopted various strategies to gain competitive advantage including product launch, mergers and acquisition, partnerships and agreements, investment, funding and others. For instance, Agilent Technologies (US) launched Infinity Lab LC / MSD iQ System in June 2019. In June 2018, Thermo Fisher Scientific (US) had introduced UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer. In 2018, Shimadzu Corp. partnered with PREMIER Biosoft, a multinational bioinformatics solutions firm, with the goal of launching its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data processing.

The regional analysis of global Glycobiology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key pharmaceutical and biopharmaceutical companies in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as evolving pharmaceutical and biopharmaceutical industries, investments by Contract Research Organizations (CROs), would create lucrative growth prospects for the Glycobiology market across Asia-Pacific region.

Major market player included in this report are:

Merck KGaA

Agilent Technologies

Thermo Fisher Scientific

New England Biolabs

Shimadzu Corporation

Takara Bio

S-BIO

Waters Corporation

Asparia Glycomics S.L.

Bio-Techne

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Enzymes

Other Enzymes

Instruments

Kits

Carbohydrates

Reagents & Chemicals

By Application:

Drug Discovery & Development

Disease Diagnostics

Other Applications

By End-user:

Academic Research Institutes

Pharmaceutical and Biotechnology Companies

Clinical Laboratories

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Glycobiology Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Glycobiology Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Glycobiology Market, by Product, 2018-2027 (USD Billion)
    • 1.2.3. Glycobiology Market, by Application, 2018-2027 (USD Billion)
    • 1.2.4. Glycobiology Market, by End-user, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Glycobiology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. End-user: Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Glycobiology Market Dynamics

  • 3.1. Glycobiology Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Glycobiology Market: End-user: Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Glycobiology Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Glycobiology Market by Product, Performance - Potential Analysis
  • 5.3. Global Glycobiology Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
  • 5.4. Glycobiology Market, Sub Segment Analysis
    • 5.4.1. Enzymes
    • 5.4.2. Other Enzymes
    • 5.4.3. Instruments
    • 5.4.4. Kits
    • 5.4.5. Carbohydrates
    • 5.4.6. Reagents & Chemicals

Chapter 6. Global Glycobiology Market, by End-user

  • 6.1. Market Snapshot
  • 6.2. Global Glycobiology Market by End-user, Performance - Potential Analysis
  • 6.3. Global Glycobiology Market Estimates & Forecasts by End-user2017-2027 (USD Billion)
  • 6.4. Glycobiology Market, Sub Segment Analysis
    • 6.4.1. Academic Research Institutes
    • 6.4.2. Pharmaceutical and Biotechnology Companies
    • 6.4.3. Clinical Laboratories

Chapter 7. Global Glycobiology Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Glycobiology Market by Application, Performance - Potential Analysis
  • 7.3. Global Glycobiology Market Estimates & Forecasts by Application2017-2027 (USD Billion)
  • 7.4. Glycobiology Market, Sub Segment Analysis
    • 7.4.1. Drug Discovery & Development
    • 7.4.2. Disease Diagnostics
    • 7.4.3. Other Applications

Chapter 8. Global Glycobiology Market, Regional Analysis

  • 8.1. Glycobiology Market, Regional Market Snapshot
  • 8.2. North America Glycobiology Market
    • 8.2.1. U.S. Glycobiology Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. End-user breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Glycobiology Market
  • 8.3. Europe Glycobiology Market Snapshot
    • 8.3.1. U.K. Glycobiology Market
    • 8.3.2. Germany Glycobiology Market
    • 8.3.3. France Glycobiology Market
    • 8.3.4. Spain Glycobiology Market
    • 8.3.5. Italy Glycobiology Market
    • 8.3.6. Rest of Europe Glycobiology Market
  • 8.4. Asia-Pacific Glycobiology Market Snapshot
    • 8.4.1. China Glycobiology Market
    • 8.4.2. India Glycobiology Market
    • 8.4.3. Japan Glycobiology Market
    • 8.4.4. Australia Glycobiology Market
    • 8.4.5. South Korea Glycobiology Market
    • 8.4.6. Rest of Asia Pacific Glycobiology Market
  • 8.5. Latin America Glycobiology Market Snapshot
    • 8.5.1. Brazil Glycobiology Market
    • 8.5.2. Mexico Glycobiology Market
  • 8.6. Rest of The World Glycobiology Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Merck KGaA
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Agilent Technologies
    • 9.2.3. Thermo Fisher Scientific
    • 9.2.4. New England Biolabs
    • 9.2.5. Shimadzu Corporation
    • 9.2.6. Takara Bio
    • 9.2.7. S-BIO
    • 9.2.8. Waters Corporation
    • 9.2.9. Asparia Glycomics S.L.
    • 9.2.10. Bio-Techne

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.